Takeda submits approval request for Novavax's COVID-19 vaccine in Japan
(Reuters) - Takeda Pharmaceutical Co Ltd has submitted an approval request for Novavax's COVID-19 vaccine to Japan's health ministry, the U.S. drugmaker said late on Wednesday.
(Reporting by Shivam Patel in Bengaluru; Editing by Sriraj Kalluvila)
(c) Copyright Thomson Reuters 2021. Click For Restrictions -